Cargando…
Glycemic Control Was Unchanged in Veterans Health Administration Patients Converted from Glyburide to Glipizide
Autores principales: | Aspinall, Sherrie L., Good, Chester B., Cunningham, Francesca E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438164/ https://www.ncbi.nlm.nih.gov/pubmed/22235958 http://dx.doi.org/10.18553/jmcp.2012.18.1.73 |
Ejemplares similares
-
Glycemic Control and Hypoglycemia in Veterans Health Administration Patients Converted from Glyburide to Glipizide
por: Skoff, Rachel A., et al.
Publicado: (2011) -
Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration
por: Aspinall, Sherrie L., et al.
Publicado: (2019) -
The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis
por: Pantalone, Kevin M., et al.
Publicado: (2010) -
Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014
por: Aspinall, Sherrie L., et al.
Publicado: (2016) -
Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers
por: Soni, Amy, et al.
Publicado: (2015)